Methods and uses for dendritic cell therapy
US11779599B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2018 |
| Grant date | Oct 10, 2023 |
| Priority date | — |
| Expiry date | Sep 26, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57438
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides methods of evaluating immune system parameters to identify and treat patients who are likely to experience more favorable treatment outcomes. This invention also provides methods for treating a human patient with a dendritic cell therapy by obtaining at least one value or measurement of the level and/or amount of a particular type of treatment indicator in the patient, confirming that said value or measurement exceeds or is less than the treatment threshold value for that value or measurement, and administering said dendritic cell therapy to the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.